Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Saliva-based Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Direct Sample to PCR
1.2.3 RT-qPCR
1.2.4 Lateral Flow Assays
1.3 Market by Application
1.3.1 Global Saliva-based Screening Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals & Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Saliva-based Screening Market Perspective (2018-2033)
2.2 Saliva-based Screening Growth Trends by Region
2.2.1 Global Saliva-based Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Saliva-based Screening Historic Market Size by Region (2018-2023)
2.2.3 Saliva-based Screening Forecasted Market Size by Region (2024-2033)
2.3 Saliva-based Screening Market Dynamics
2.3.1 Saliva-based Screening Industry Trends
2.3.2 Saliva-based Screening Market Drivers
2.3.3 Saliva-based Screening Market Challenges
2.3.4 Saliva-based Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Saliva-based Screening Players by Revenue
3.1.1 Global Top Saliva-based Screening Players by Revenue (2018-2023)
3.1.2 Global Saliva-based Screening Revenue Market Share by Players (2018-2023)
3.2 Global Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Saliva-based Screening Revenue
3.4 Global Saliva-based Screening Market Concentration Ratio
3.4.1 Global Saliva-based Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Saliva-based Screening Revenue in 2022
3.5 Saliva-based Screening Key Players Head office and Area Served
3.6 Key Players Saliva-based Screening Product Solution and Service
3.7 Date of Enter into Saliva-based Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Saliva-based Screening Breakdown Data by Type
4.1 Global Saliva-based Screening Historic Market Size by Type (2018-2023)
4.2 Global Saliva-based Screening Forecasted Market Size by Type (2024-2033)
5 Saliva-based Screening Breakdown Data by Application
5.1 Global Saliva-based Screening Historic Market Size by Application (2018-2023)
5.2 Global Saliva-based Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Saliva-based Screening Market Size (2018-2033)
6.2 North America Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Saliva-based Screening Market Size by Country (2018-2023)
6.4 North America Saliva-based Screening Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Saliva-based Screening Market Size (2018-2033)
7.2 Europe Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Saliva-based Screening Market Size by Country (2018-2023)
7.4 Europe Saliva-based Screening Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Saliva-based Screening Market Size (2018-2033)
8.2 Asia-Pacific Saliva-based Screening Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Saliva-based Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Saliva-based Screening Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Saliva-based Screening Market Size (2018-2033)
9.2 Latin America Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Saliva-based Screening Market Size by Country (2018-2023)
9.4 Latin America Saliva-based Screening Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Saliva-based Screening Market Size (2018-2033)
10.2 Middle East & Africa Saliva-based Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Saliva-based Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Saliva-based Screening Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher scientific
11.1.1 Thermo Fisher scientific Company Detail
11.1.2 Thermo Fisher scientific Business Overview
11.1.3 Thermo Fisher scientific Saliva-based Screening Introduction
11.1.4 Thermo Fisher scientific Revenue in Saliva-based Screening Business (2018-2023)
11.1.5 Thermo Fisher scientific Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Saliva-based Screening Introduction
11.2.4 Qiagen Revenue in Saliva-based Screening Business (2018-2023)
11.2.5 Qiagen Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic Saliva-based Screening Introduction
11.3.4 Hologic Revenue in Saliva-based Screening Business (2018-2023)
11.3.5 Hologic Recent Development
11.4 Takara Bio Inc
11.4.1 Takara Bio Inc Company Detail
11.4.2 Takara Bio Inc Business Overview
11.4.3 Takara Bio Inc Saliva-based Screening Introduction
11.4.4 Takara Bio Inc Revenue in Saliva-based Screening Business (2018-2023)
11.4.5 Takara Bio Inc Recent Development
11.5 Arcis Biotechnology Limited
11.5.1 Arcis Biotechnology Limited Company Detail
11.5.2 Arcis Biotechnology Limited Business Overview
11.5.3 Arcis Biotechnology Limited Saliva-based Screening Introduction
11.5.4 Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2018-2023)
11.5.5 Arcis Biotechnology Limited Recent Development
11.6 GeneProof
11.6.1 GeneProof Company Detail
11.6.2 GeneProof Business Overview
11.6.3 GeneProof Saliva-based Screening Introduction
11.6.4 GeneProof Revenue in Saliva-based Screening Business (2018-2023)
11.6.5 GeneProof Recent Development
11.7 Abacus ALS
11.7.1 Abacus ALS Company Detail
11.7.2 Abacus ALS Business Overview
11.7.3 Abacus ALS Saliva-based Screening Introduction
11.7.4 Abacus ALS Revenue in Saliva-based Screening Business (2018-2023)
11.7.5 Abacus ALS Recent Development
11.8 Chai Inc.
11.8.1 Chai Inc. Company Detail
11.8.2 Chai Inc. Business Overview
11.8.3 Chai Inc. Saliva-based Screening Introduction
11.8.4 Chai Inc. Revenue in Saliva-based Screening Business (2018-2023)
11.8.5 Chai Inc. Recent Development
11.9 Kolplast Group
11.9.1 Kolplast Group Company Detail
11.9.2 Kolplast Group Business Overview
11.9.3 Kolplast Group Saliva-based Screening Introduction
11.9.4 Kolplast Group Revenue in Saliva-based Screening Business (2018-2023)
11.9.5 Kolplast Group Recent Development
11.10 Lucence Health INc
11.10.1 Lucence Health INc Company Detail
11.10.2 Lucence Health INc Business Overview
11.10.3 Lucence Health INc Saliva-based Screening Introduction
11.10.4 Lucence Health INc Revenue in Saliva-based Screening Business (2018-2023)
11.10.5 Lucence Health INc Recent Development
11.11 Vitagene
11.11.1 Vitagene Company Detail
11.11.2 Vitagene Business Overview
11.11.3 Vitagene Saliva-based Screening Introduction
11.11.4 Vitagene Revenue in Saliva-based Screening Business (2018-2023)
11.11.5 Vitagene Recent Development
11.12 Therma Bright Inc
11.12.1 Therma Bright Inc Company Detail
11.12.2 Therma Bright Inc Business Overview
11.12.3 Therma Bright Inc Saliva-based Screening Introduction
11.12.4 Therma Bright Inc Revenue in Saliva-based Screening Business (2018-2023)
11.12.5 Therma Bright Inc Recent Development
11.13 ACON Laboratories, Inc
11.13.1 ACON Laboratories, Inc Company Detail
11.13.2 ACON Laboratories, Inc Business Overview
11.13.3 ACON Laboratories, Inc Saliva-based Screening Introduction
11.13.4 ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2018-2023)
11.13.5 ACON Laboratories, Inc Recent Development
11.14 TODA PHARMA
11.14.1 TODA PHARMA Company Detail
11.14.2 TODA PHARMA Business Overview
11.14.3 TODA PHARMA Saliva-based Screening Introduction
11.14.4 TODA PHARMA Revenue in Saliva-based Screening Business (2018-2023)
11.14.5 TODA PHARMA Recent Development
11.15 Norgen Biotek Corp.
11.15.1 Norgen Biotek Corp. Company Detail
11.15.2 Norgen Biotek Corp. Business Overview
11.15.3 Norgen Biotek Corp. Saliva-based Screening Introduction
11.15.4 Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2018-2023)
11.15.5 Norgen Biotek Corp. Recent Development
11.16 Assure Tech. (Hangzhou) Co., Ltd
11.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Detail
11.16.2 Assure Tech. (Hangzhou) Co., Ltd Business Overview
11.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Introduction
11.16.4 Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Development
11.17 Beijing Hotgen Biotech Co., Ltd
11.17.1 Beijing Hotgen Biotech Co., Ltd Company Detail
11.17.2 Beijing Hotgen Biotech Co., Ltd Business Overview
11.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Introduction
11.17.4 Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.17.5 Beijing Hotgen Biotech Co., Ltd Recent Development
11.18 Nantong Diagnos Biotechnology Co., Ltd
11.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Detail
11.18.2 Nantong Diagnos Biotechnology Co., Ltd Business Overview
11.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Introduction
11.18.4 Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Development
11.19 NeuMoDx Molecular, Inc.
11.19.1 NeuMoDx Molecular, Inc. Company Detail
11.19.2 NeuMoDx Molecular, Inc. Business Overview
11.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Introduction
11.19.4 NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2018-2023)
11.19.5 NeuMoDx Molecular, Inc. Recent Development
11.20 KYODO INTERNATIONAL INC.
11.20.1 KYODO INTERNATIONAL INC. Company Detail
11.20.2 KYODO INTERNATIONAL INC. Business Overview
11.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Introduction
11.20.4 KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2018-2023)
11.20.5 KYODO INTERNATIONAL INC. Recent Development
11.21 Canvax
11.21.1 Canvax Company Detail
11.21.2 Canvax Business Overview
11.21.3 Canvax Saliva-based Screening Introduction
11.21.4 Canvax Revenue in Saliva-based Screening Business (2018-2023)
11.21.5 Canvax Recent Development
11.22 Zymo Research Corporation.
11.22.1 Zymo Research Corporation. Company Detail
11.22.2 Zymo Research Corporation. Business Overview
11.22.3 Zymo Research Corporation. Saliva-based Screening Introduction
11.22.4 Zymo Research Corporation. Revenue in Saliva-based Screening Business (2018-2023)
11.22.5 Zymo Research Corporation. Recent Development
11.23 Salimetrics
11.23.1 Salimetrics Company Detail
11.23.2 Salimetrics Business Overview
11.23.3 Salimetrics Saliva-based Screening Introduction
11.23.4 Salimetrics Revenue in Saliva-based Screening Business (2018-2023)
11.23.5 Salimetrics Recent Development
11.24 NEST Scientific USA
11.24.1 NEST Scientific USA Company Detail
11.24.2 NEST Scientific USA Business Overview
11.24.3 NEST Scientific USA Saliva-based Screening Introduction
11.24.4 NEST Scientific USA Revenue in Saliva-based Screening Business (2018-2023)
11.24.5 NEST Scientific USA Recent Development
11.25 Miraclean Technology Co. Ltd
11.25.1 Miraclean Technology Co. Ltd Company Detail
11.25.2 Miraclean Technology Co. Ltd Business Overview
11.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Introduction
11.25.4 Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2018-2023)
11.25.5 Miraclean Technology Co. Ltd Recent Development
11.26 Mawi DNA Technologies
11.26.1 Mawi DNA Technologies Company Detail
11.26.2 Mawi DNA Technologies Business Overview
11.26.3 Mawi DNA Technologies Saliva-based Screening Introduction
11.26.4 Mawi DNA Technologies Revenue in Saliva-based Screening Business (2018-2023)
11.26.5 Mawi DNA Technologies Recent Development
11.27 Cell Projects Ltd.
11.27.1 Cell Projects Ltd. Company Detail
11.27.2 Cell Projects Ltd. Business Overview
11.27.3 Cell Projects Ltd. Saliva-based Screening Introduction
11.27.4 Cell Projects Ltd. Revenue in Saliva-based Screening Business (2018-2023)
11.27.5 Cell Projects Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Saliva-based Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Direct Sample to PCR
Table 3. Key Players of RT-qPCR
Table 4. Key Players of Lateral Flow Assays
Table 5. Global Saliva-based Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Saliva-based Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Saliva-based Screening Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Saliva-based Screening Market Share by Region (2018-2023)
Table 9. Global Saliva-based Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Saliva-based Screening Market Share by Region (2024-2033)
Table 11. Saliva-based Screening Market Trends
Table 12. Saliva-based Screening Market Drivers
Table 13. Saliva-based Screening Market Challenges
Table 14. Saliva-based Screening Market Restraints
Table 15. Global Saliva-based Screening Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Saliva-based Screening Market Share by Players (2018-2023)
Table 17. Global Top Saliva-based Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2022)
Table 18. Ranking of Global Top Saliva-based Screening Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Saliva-based Screening Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Saliva-based Screening Product Solution and Service
Table 22. Date of Enter into Saliva-based Screening Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Saliva-based Screening Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Saliva-based Screening Revenue Market Share by Type (2018-2023)
Table 26. Global Saliva-based Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Saliva-based Screening Revenue Market Share by Type (2024-2033)
Table 28. Global Saliva-based Screening Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Saliva-based Screening Revenue Market Share by Application (2018-2023)
Table 30. Global Saliva-based Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Saliva-based Screening Revenue Market Share by Application (2024-2033)
Table 32. North America Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Saliva-based Screening Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Saliva-based Screening Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Saliva-based Screening Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Saliva-based Screening Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Saliva-based Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Saliva-based Screening Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Saliva-based Screening Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Saliva-based Screening Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Saliva-based Screening Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Saliva-based Screening Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Saliva-based Screening Market Size by Country (2024-2033) & (US$ Million)
Table 47. Thermo Fisher scientific Company Detail
Table 48. Thermo Fisher scientific Business Overview
Table 49. Thermo Fisher scientific Saliva-based Screening Product
Table 50. Thermo Fisher scientific Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 51. Thermo Fisher scientific Recent Development
Table 52. Qiagen Company Detail
Table 53. Qiagen Business Overview
Table 54. Qiagen Saliva-based Screening Product
Table 55. Qiagen Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 56. Qiagen Recent Development
Table 57. Hologic Company Detail
Table 58. Hologic Business Overview
Table 59. Hologic Saliva-based Screening Product
Table 60. Hologic Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 61. Hologic Recent Development
Table 62. Takara Bio Inc Company Detail
Table 63. Takara Bio Inc Business Overview
Table 64. Takara Bio Inc Saliva-based Screening Product
Table 65. Takara Bio Inc Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 66. Takara Bio Inc Recent Development
Table 67. Arcis Biotechnology Limited Company Detail
Table 68. Arcis Biotechnology Limited Business Overview
Table 69. Arcis Biotechnology Limited Saliva-based Screening Product
Table 70. Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 71. Arcis Biotechnology Limited Recent Development
Table 72. GeneProof Company Detail
Table 73. GeneProof Business Overview
Table 74. GeneProof Saliva-based Screening Product
Table 75. GeneProof Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 76. GeneProof Recent Development
Table 77. Abacus ALS Company Detail
Table 78. Abacus ALS Business Overview
Table 79. Abacus ALS Saliva-based Screening Product
Table 80. Abacus ALS Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 81. Abacus ALS Recent Development
Table 82. Chai Inc. Company Detail
Table 83. Chai Inc. Business Overview
Table 84. Chai Inc. Saliva-based Screening Product
Table 85. Chai Inc. Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 86. Chai Inc. Recent Development
Table 87. Kolplast Group Company Detail
Table 88. Kolplast Group Business Overview
Table 89. Kolplast Group Saliva-based Screening Product
Table 90. Kolplast Group Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 91. Kolplast Group Recent Development
Table 92. Lucence Health INc Company Detail
Table 93. Lucence Health INc Business Overview
Table 94. Lucence Health INc Saliva-based Screening Product
Table 95. Lucence Health INc Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 96. Lucence Health INc Recent Development
Table 97. Vitagene Company Detail
Table 98. Vitagene Business Overview
Table 99. Vitagene Saliva-based Screening Product
Table 100. Vitagene Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 101. Vitagene Recent Development
Table 102. Therma Bright Inc Company Detail
Table 103. Therma Bright Inc Business Overview
Table 104. Therma Bright Inc Saliva-based Screening Product
Table 105. Therma Bright Inc Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 106. Therma Bright Inc Recent Development
Table 107. ACON Laboratories, Inc Company Detail
Table 108. ACON Laboratories, Inc Business Overview
Table 109. ACON Laboratories, Inc Saliva-based Screening Product
Table 110. ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 111. ACON Laboratories, Inc Recent Development
Table 112. TODA PHARMA Company Detail
Table 113. TODA PHARMA Business Overview
Table 114. TODA PHARMA Saliva-based Screening Product
Table 115. TODA PHARMA Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 116. TODA PHARMA Recent Development
Table 117. Norgen Biotek Corp. Company Detail
Table 118. Norgen Biotek Corp. Business Overview
Table 119. Norgen Biotek Corp. Saliva-based Screening Product
Table 120. Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 121. Norgen Biotek Corp. Recent Development
Table 122. Assure Tech. (Hangzhou) Co., Ltd Company Detail
Table 123. Assure Tech. (Hangzhou) Co., Ltd Business Overview
Table 124. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product
Table 125. Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 126. Assure Tech. (Hangzhou) Co., Ltd Recent Development
Table 127. Beijing Hotgen Biotech Co., Ltd Company Detail
Table 128. Beijing Hotgen Biotech Co., Ltd Business Overview
Table 129. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product
Table 130. Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 131. Beijing Hotgen Biotech Co., Ltd Recent Development
Table 132. Nantong Diagnos Biotechnology Co., Ltd Company Detail
Table 133. Nantong Diagnos Biotechnology Co., Ltd Business Overview
Table 134. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product
Table 135. Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 136. Nantong Diagnos Biotechnology Co., Ltd Recent Development
Table 137. NeuMoDx Molecular, Inc. Company Detail
Table 138. NeuMoDx Molecular, Inc. Business Overview
Table 139. NeuMoDx Molecular, Inc. Saliva-based Screening Product
Table 140. NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 141. NeuMoDx Molecular, Inc. Recent Development
Table 142. KYODO INTERNATIONAL INC. Company Detail
Table 143. KYODO INTERNATIONAL INC. Business Overview
Table 144. KYODO INTERNATIONAL INC. Saliva-based Screening Product
Table 145. KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 146. KYODO INTERNATIONAL INC. Recent Development
Table 147. Canvax Company Detail
Table 148. Canvax Business Overview
Table 149. Canvax Saliva-based Screening Product
Table 150. Canvax Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 151. Canvax Recent Development
Table 152. Zymo Research Corporation. Company Detail
Table 153. Zymo Research Corporation. Business Overview
Table 154. Zymo Research Corporation. Saliva-based Screening Product
Table 155. Zymo Research Corporation. Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 156. Zymo Research Corporation. Recent Development
Table 157. Salimetrics Company Detail
Table 158. Salimetrics Business Overview
Table 159. Salimetrics Saliva-based Screening Product
Table 160. Salimetrics Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 161. Salimetrics Recent Development
Table 162. NEST Scientific USA Company Detail
Table 163. NEST Scientific USA Business Overview
Table 164. NEST Scientific USA Saliva-based Screening Product
Table 165. NEST Scientific USA Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 166. NEST Scientific USA Recent Development
Table 167. Miraclean Technology Co. Ltd Company Detail
Table 168. Miraclean Technology Co. Ltd Business Overview
Table 169. Miraclean Technology Co. Ltd Saliva-based Screening Product
Table 170. Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 171. Miraclean Technology Co. Ltd Recent Development
Table 172. Mawi DNA Technologies Company Detail
Table 173. Mawi DNA Technologies Business Overview
Table 174. Mawi DNA Technologies Saliva-based Screening Product
Table 175. Mawi DNA Technologies Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 176. Mawi DNA Technologies Recent Development
Table 177. Cell Projects Ltd. Company Detail
Table 178. Cell Projects Ltd. Business Overview
Table 179. Cell Projects Ltd. Saliva-based Screening Product
Table 180. Cell Projects Ltd. Revenue in Saliva-based Screening Business (2018-2023) & (US$ Million)
Table 181. Cell Projects Ltd. Recent Development
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Saliva-based Screening Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Saliva-based Screening Market Share by Type: 2022 VS 2033
Figure 3. Direct Sample to PCR Features
Figure 4. RT-qPCR Features
Figure 5. Lateral Flow Assays Features
Figure 6. Global Saliva-based Screening Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Saliva-based Screening Market Share by Application: 2022 VS 2033
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Saliva-based Screening Report Years Considered
Figure 12. Global Saliva-based Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Saliva-based Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Saliva-based Screening Market Share by Region: 2022 VS 2033
Figure 15. Global Saliva-based Screening Market Share by Players in 2022
Figure 16. Global Top Saliva-based Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Saliva-based Screening Revenue in 2022
Figure 18. North America Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Saliva-based Screening Market Share by Country (2018-2033)
Figure 20. United States Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Saliva-based Screening Market Share by Country (2018-2033)
Figure 24. Germany Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Saliva-based Screening Market Share by Region (2018-2033)
Figure 32. China Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Saliva-based Screening Market Share by Country (2018-2033)
Figure 40. Mexico Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Saliva-based Screening Market Share by Country (2018-2033)
Figure 44. Turkey Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Saliva-based Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Thermo Fisher scientific Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 47. Qiagen Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 48. Hologic Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 49. Takara Bio Inc Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 50. Arcis Biotechnology Limited Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 51. GeneProof Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 52. Abacus ALS Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 53. Chai Inc. Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 54. Kolplast Group Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 55. Lucence Health INc Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 56. Vitagene Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 57. Therma Bright Inc Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 58. ACON Laboratories, Inc Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 59. TODA PHARMA Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 60. Norgen Biotek Corp. Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 61. Assure Tech. (Hangzhou) Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 62. Beijing Hotgen Biotech Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 63. Nantong Diagnos Biotechnology Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 64. NeuMoDx Molecular, Inc. Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 65. KYODO INTERNATIONAL INC. Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 66. Canvax Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 67. Zymo Research Corporation. Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 68. Salimetrics Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 69. NEST Scientific USA Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 70. Miraclean Technology Co. Ltd Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 71. Mawi DNA Technologies Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 72. Cell Projects Ltd. Revenue Growth Rate in Saliva-based Screening Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed